Loading…
Loading…
EQUITY / NASDAQ · XNCM
Akso Health Group ADR
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2025 – 03/31/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.9 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 0.9 USD · Volume 5,643,315
63 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
5 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2025 – 03/31/2026 · Units
| Metric | 2026 / Year end | 2025 / Year end | Change |
|---|---|---|---|
| Revenue | 13,831,904 USD | 14,777,798 USD | -6.40% |
| Operating profit | -20,700,332 USD | -166,304,352 USD | — |
| Net income | -18,671,610 USD | -134,977,369 USD | — |
| Operating cash flow | -12,791,300 USD | 1,177,163 USD | -1,186.62% |
| Cash and cash equivalents | 170,572 USD | 176,229,874 USD | -99.90% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Year end04/01/2025 – 03/31/2026ConsolidatedUnits · USD | 2025 / Year end04/01/2024 – 03/31/2025ConsolidatedUnits · USD | 2024 / Year end04/01/2023 – 03/31/2024ConsolidatedUnits · USD | 2023 / Year end03/31/2023 – 03/31/2023ConsolidatedUnits · USD | 2023 / Year end04/01/2022 – 03/31/2023ConsolidatedUnits · USD |
|---|---|---|---|---|---|
| Capital expendituresCash flow statement | 1,638 USD | 154,460 USD | — | — | — |
| Cash and cash equivalentsBalance sheet | 170,572 USD | 176,229,874 USD | 85,174,017 USD | — | 7,924,468 USD |
| Financing cash flowCash flow statement | 350,000 USD | 195,884,024 USD | 131,653,697 USD | — | -27,513,848 USD |
| Gross profitIncome statement | -11,315 USD | -281,526 USD | 122,132 USD | — | 1,268,990 USD |
| Investing cash flowCash flow statement | -163,464,519 USD | -105,912,692 USD | -54,721,082 USD | — | 18,471,082 USD |
| Net incomeIncome statement | -18,671,610 USD | -134,977,369 USD | -9,458,784 USD | — | -1,359,923 USD |
| Operating cash flowCash flow statement | -12,791,300 USD | 1,177,163 USD | 1,351,240 USD | — | -3,253,340 USD |
| Operating profitIncome statement | -20,700,332 USD | -166,304,352 USD | -8,638,040 USD | — | -14,266,853 USD |
| RevenueIncome statement | 13,831,904 USD | 14,777,798 USD | 2,414,338 USD | — | 13,181,561 USD |
| Total assetsBalance sheet | 189,633,385 USD | 214,953,325 USD | — | — | — |
| Total equityBalance sheet | 180,934,612 USD | 199,119,145 USD | 138,424,194 USD | 8,839,516 USD | 8,839,516 USD |
| Total liabilitiesBalance sheet | 8,711,006 USD | 15,802,189 USD | — | — | — |
| Report source | Open report ↗ Published: 07/23/2026 | Open report ↗ Published: 07/23/2026 | Open report ↗ Published: 07/23/2026 | Open report ↗ Published: 07/23/2026 | Open report ↗ Published: 08/14/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.